Ourania Tsitsilonis
Ourania Tsitsilonis
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα biol.uoa.gr - Αρχική σελίδα
ΤίτλοςΠαρατίθεται απόΈτος
Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor
CN Baxevanis, IF Voutsas, OE Tsitsilonis, AD Gritzapis, R Sotiriadou, ...
The Journal of Immunology 164 (7), 3902-3912, 2000
1812000
Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice
CN Baxevanis, IF Voutsas, OE Tsitsilonis, ML Tsiatas, AD Gritzapis, ...
European journal of immunology 30 (7), 1957-1966, 2000
1062000
Harnessing the immune system to improve cancer therapy
NE Papaioannou, OV Beniata, P Vitsos, O Tsitsilonis, P Samara
Annals of translational medicine 4 (14), 2016
1022016
Correlation of NK T-like CD3+ CD56+ cells and CD4+ CD25+ (hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum …
A Bamias, V Koutsoukou, E Terpos, ML Tsiatas, C Liakos, O Tsitsilonis, ...
Gynecologic oncology 108 (2), 421-427, 2008
912008
Expression of alpha-thymosins in human tissues in normal and abnormal growth
OE Tsitsiloni, J Stiakakis, A Koutselinis, J Gogas, C Markopoulos, ...
Proceedings of the National Academy of Sciences 90 (20), 9504-9507, 1993
861993
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
AC Ziogas, NG Gavalas, M Tsiatas, O Tsitsilonis, E Politi, E Terpos, ...
International journal of cancer 130 (4), 857-864, 2012
772012
Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis
F Sesti, OE Tsitsilonis, A Kotsinas, IP Trougakos
In Vivo 26 (3), 395-402, 2012
742012
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+ CD56+ cells with …
A Bamias, ML Tsiatas, E Kafantari, C Liakou, A Rodolakis, Z Voulgaris, ...
Gynecologic oncology 106 (1), 75-81, 2007
712007
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
NG Gavalas, M Tsiatas, O Tsitsilonis, E Politi, K Ioannou, AC Ziogas, ...
British journal of cancer 107 (11), 1869, 2012
632012
HER‐2/neu–derived peptide epitopes are also recognized by cytotoxic CD3+CD56+ (natural killer T) lymphocytes
CN Baxevanis, AD Gritzapis, OE Tsitsilonis, HL Katsoulas, M Papamichail
International journal of cancer 98 (6), 864-872, 2002
532002
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy
K Ioannou, P Samara, E Livaniou, E Derhovanessian, OE Tsitsilonis
Cancer Immunology, Immunotherapy 61 (5), 599-614, 2012
422012
Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving antic ancer vaccination strategies
CN Baxevanis, IF Voutsas, OE Tsitsilonis
Immunotherapy 5 (5), 497-511, 2013
402013
Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicity
CN Baxevanis, IF Voutsas, MH Soler, AD Gritzapis, OE Tsitsilonis, ...
Immunopharmacology and immunotoxicology 20 (3), 355-372, 1998
391998
Proteomic exploitation on prothymosin α‐induced mononuclear cell activation
M Skopeliti, U Kratzer, F Altenberend, G Panayotou, H Kalbacher, ...
Proteomics 7 (11), 1814-1824, 2007
372007
The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients
M Skopeliti, IF Voutsas, P Klimentzou, ML Tsiatas, A Beck, A Bamias, ...
Cancer Immunology, Immunotherapy 55 (10), 1247-1257, 2006
372006
Prothymosin α immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a β-sheet conformation in a …
M Skopeliti, VA Iconomidou, E Derhovanessian, G Pawelec, W Voelter, ...
Molecular immunology 46 (5), 784-792, 2009
362009
Cytotoxicity and immunomodulating characteristics of labdane diterpenes from Marrubium cylleneum and Marrubium velutinum
A Karioti, M Skopeliti, O Tsitsilonis, J Heilmann, H Skaltsa
Phytochemistry 68 (11), 1587-1594, 2007
362007
The prognostic value of alpha-thymosins in breast cancer.
OE Tsitsilonis, E Bekris, IF Voutsas, CN Baxevanis, C Markopoulos, ...
Anticancer research 18 (3A), 1501-1508, 1998
361998
Polar Constituents of Marrubium thessalum Boiss. & Heldr. (Lamiaceae) and their Cytotoxic/Cytostatic Activity
A Argyropoulou, P Samara, O Tsitsilonis, H Skaltsa
Phytotherapy Research 26 (12), 1800-1806, 2012
332012
Induction of tumor-specific T lymphocyte responses in vivo by prothymosin α
CN Baxevanis, AD Gritzapis, G Spanakos, OE Tsitsilonis, M Papamichail
Cancer Immunology, Immunotherapy 40 (6), 410-418, 1995
321995
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20